Frontiers in Immunology

Frontiers in Immunology is a peer-reviewed Open Access Journal, and the official Journal of theInternational Union of Immunological Societies (IUIS). It provides a novel way to disseminate the latest findings in basic and translational research in Immunology and to facilitate communication, both among scientists as well as the community at large.Frontiers in Immunology aims to publish the most outstanding research findings encompassing the entire field of Immunology. In addition to papers that investigate basic mechanisms of immune system development and function, a particular emphasis is given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis. Furthermore, availability of a growing number of biological drugs, coupled with fine characterization of the molecular mechanisms of disease, has now made precision medicine a desirable approach for many immunological disorders. Frontiers in Immunology intends to portray how advances of scientific knowledge and technology may translate into novel approaches to diagnosis and treatment of immune disorders, both in animal and cellular models and in humans.All manuscripts submitted to Frontiers in Immunology that report on studies conducted in human subjects must conform with current regulation and the Declaration of Helsinki, and must receive approval from the Institutional Review Board and patient informed consent. Animal welfare and Ethics Committee approval is required for studies involving animals.Frontiers in Immunology is organized into Specialty Sections that cover different areas of research in Immunology. Authors should refer to the author guidelines for details on article types and the submission process.

《免疫学前沿》是一份经过同行评审的开放获取期刊，也是国际免疫学会联盟(IUIS)的官方期刊。它提供了一种新的方式来传播免疫学基础和转化研究的最新发现，并促进科学家之间以及整个社区之间的交流。《免疫学前沿》旨在发表涵盖整个免疫学领域的最杰出的研究成果。除了研究免疫系统发育和功能的基本机制的论文外，还特别强调了对人类免疫疾病的临床和免疫表型的描述，以及对其分子基础的定义。此外，越来越多的生物药物的可用性，加上对疾病分子机制的精细描述，现在已使精确医学成为许多免疫性疾病的理想方法。免疫学前沿旨在描述科学知识和技术的进步如何转化为诊断和治疗免疫疾病的新方法，无论是在动物和细胞模型中，还是在人类中。所有提交给《免疫学前沿》的关于人体研究报告的手稿都必须符合现行法规和《赫尔辛基宣言》，并且必须得到机构审查委员会的批准和患者知情同意。涉及动物的研究需要获得动物福利和伦理委员会的批准。免疫学前沿被组织成涵盖免疫学研究不同领域的专业部门。关于文章类型和提交过程的详细信息，作者应该参考作者指南。